Infographics - Organ Transplant Immunosuppressant Drugs Market

After a successful organ transplant, you may have to take immunosuppressant drugs. These drugs help your immune system from attacking (rejecting) the new organ from which it has been transplanted. In general, they should be taken for your lifetime, or until the treatments are complete. Orally, or injected into a vein, these drugs work by stopping your body's immune cells from further attacking your transplanted organ. They also control your allergic reactions to the transplanted organ and reduce inflammation around the transplanted tissues.

Market Dynamics:

Approval and launch of new drugs is expected to propel growth of the global organ transplant immunosuppressant drugs market over the forecast period. For instance, in July 2021, Kadmon Holdings, Inc. received the U.S. Food and Drug Administration approval for REZUROCK (belumosudil) for the treatment of adult and pediatric patients with chronic graft-versus-host disease.

Negative outcomes in clinical trials is expected to hinder growth of the global organ transplant immunosuppressant drugs market. For instance, in September 2021, Novartis AG announced to halt a mid-stage clinical trial of drug intended to prevent organ rejection after an early look at data in kidney transplant patients showed the experimental treatment was less effective compared to the standard of care therapy.

The market is witnessing several M&A activities. For instance, in September 2021, Sanofi announced to acquire Kadmon Holdings, a U.S.-based biopharmaceutical company.

Key features of the study:

This report provides in-depth analysis of the global organ transplant immunosuppressant drugs market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global organ transplant immunosuppressant drugs market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Astellas Pharma, Genzyme Corporation, Accord Healthcare Ltd., Watson Pharmaceuticals, Inc., Novartis AG, Mylan Laboratories, Inc., GlaxoSmithKline plc., Belcher Pharmaceuticals LLC, Leo Pharma As, Glenmark Pharmaceuticals Ltd., TFF Pharmaceuticals, Inc., TolerogenixX GmbH, Veloxis Pharmaceuticals Inc., Dr. Reddy’s Laboratories Ltd., Panacea Biotec Ltd., Strides Pharma Global Pte Ltd., and Hoffman La Roche Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global organ transplant immunosuppressant drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global organ transplant immunosuppressant drugs market

Detailed Segmentation:

Global Organ Transplant Immunosuppressant Drugs Market, By Drug Class:
- Calcineurin Inhibitors
- Antiproliferative Agents
- mTOR Inhibitor
- Steroids
- Antibodies
Global Organ Transplant Immunosuppressant Drugs Market, By Transplant Type:
- Kidney
- Liver
- Heart
- Lung
- Pancreas
- Others
Global Organ Transplant Immunosuppressant Drugs Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Organ Transplant Immunosuppressant Drugs Market, By Region:
- North America
  - North America Organ Transplant Immunosuppressant Drugs Market , By Drug Class:
    - Calcineurin Inhibitors
    - Antiproliferative Agents
    - mTOR Inhibitor
    - Steroids
    - Antibodies
  - North America Organ Transplant Immunosuppressant Drugs Market , By Transplant Type:
    - Kidney
    - Liver
    - Heart
    - Lung
    - Pancreas
    - Others
  - North America Organ Transplant Immunosuppressant Drugs Market , By Distribution Channel:
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
North America Organ Transplant Immunosuppressant Drugs Market , By Country:
- - - U.S.
    - Canada
- Latin America
  - Latin America Organ Transplant Immunosuppressant Drugs Market , By Drug Class:
    - Calcineurin Inhibitors
    - Antiproliferative Agents
    - mTOR Inhibitor
    - Steroids
    - Antibodies
  - Latin America Organ Transplant Immunosuppressant Drugs Market , By Transplant Type:
    - Kidney
    - Liver
    - Heart
    - Lung
    - Pancreas
    - Others
  - Latin America Organ Transplant Immunosuppressant Drugs Market , By Distribution Channel:
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
  - Latin America Organ Transplant Immunosuppressant Drugs Market , By Country:
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Europe Organ Transplant Immunosuppressant Drugs Market , By Drug Class:
    - Calcineurin Inhibitors
    - Antiproliferative Agents
    - mTOR Inhibitor
    - Steroids
    - Antibodies
  - Europe Organ Transplant Immunosuppressant Drugs Market , By Transplant Type:
    - Kidney
    - Liver
    - Heart
    - Lung
    - Pancreas
    - Others
  - Europe Organ Transplant Immunosuppressant Drugs Market , By Distribution Channel:
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
  - Europe Organ Transplant Immunosuppressant Drugs Market , By Country:
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Asia Pacific Organ Transplant Immunosuppressant Drugs Market, By Drug Class:
    - Calcineurin Inhibitors
    - Antiproliferative Agents
    - mTOR Inhibitor
    - Steroids
    - Antibodies
  - Asia Pacific Organ Transplant Immunosuppressant Drugs Market , By Transplant Type:
    - Kidney
    - Liver
    - Heart
    - Lung
    - Pancreas
    - Others
  - Asia Pacific Organ Transplant Immunosuppressant Drugs Market , By Distribution Channel:
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
  - Asia Pacific Organ Transplant Immunosuppressant Drugs Market , By Country:
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Middle East Organ Transplant Immunosuppressant Drugs Market, By Drug Class:
    - Calcineurin Inhibitors
    - Antiproliferative Agents
    - mTOR Inhibitor
    - Steroids
    - Antibodies
  - Middle East Organ Transplant Immunosuppressant Drugs Market, By Transplant Type:
    - Kidney
    - Liver
    - Heart
    - Lung
    - Pancreas
    - Others
  - Middle East Organ Transplant Immunosuppressant Drugs Market , By Distribution Channel:
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
  - Middle East Organ Transplant Immunosuppressant Drugs Market, By Country:
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Africa Organ Transplant Immunosuppressant Drugs Market, By Drug Class:
    - Calcineurin Inhibitors
    - Antiproliferative Agents
    - mTOR Inhibitor
    - Steroids
    - Antibodies
  - Middle East Organ Transplant Immunosuppressant Drugs Market, By Transplant Type:
    - Kidney
    - Liver
    - Heart
    - Lung
    - Pancreas
    - Others
  - Middle East Organ Transplant Immunosuppressant Drugs Market, By Distribution Channel:
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
  - Middle East Organ Transplant Immunosuppressant Drugs Market, By Country:
    - North Africa
    - Central Africa
    - South Africa
Company Profiles
- Astellas Pharma*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategy
- Genzyme Corporation
- Accord Healthcare Ltd.
- Watson Pharmaceuticals, Inc.
- Novartis AG
- Mylan Laboratories, Inc.
- GlaxoSmithKline plc.
- Belcher Pharmaceuticals LLC
- Leo Pharma AS
- Glenmark Pharmaceuticals Ltd.
- TFF Pharmaceuticals, Inc.
- TolerogenixX GmbH
- Veloxis Pharmaceuticals Inc.
- Reddy’s Laboratories Ltd.
- Panacea Biotec Ltd.
- Strides Pharma Global Pte Ltd.
- F-Hoffman La Roche

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Drug Class
  - Market Snippet, By Transplant Type
  - Market Snippet, By Distribution Channel
  - Market Snippet, By Region
  - Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Recent Trends
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- PORTER’s Analysis
Global Organ Transplant Immunosuppressant Drugs Market - COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
Global Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2018 - 2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019 - 2030
  - Segment Trends
- Calcineurin Inhibitors
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  - Segment Trends
- Antiproliferative Agents
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  - Segment Trends
- mTOR Inhibitor
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  - Segment Trends
- Steroids
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  - Segment Trends
- Antibodies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  - Segment Trends
Global Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2018 - 2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019 - 2030
  - Segment Trends
- Kidney
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  - Segment Trends
- Liver
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  - Segment Trends
- Heart
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  - Segment Trends
- Lung
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  - Segment Trends
- Pancreas
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  - Segment Trends
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  - Segment Trends
Global Organ Transplant Immunosuppressant Drugs Market, By Distribution Channel, 2018 - 2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019 - 2030
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Global Organ Transplant Immunosuppressant Drugs Market, By Region, 2018 - 2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019 - 2030
  - Segment Trends
- North America
  - Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2018–2030, (US$ Bn)
  - Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 –2030, (US$ Bn)
    - U.S.
    - Canada
- Europe
  - Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2018 -2030, (US$ Bn)
  - Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2018 -2030, (US$ Bn)
  - Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Middle East
  - Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2018 -2030, (US$ Bn)
  - Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
  - Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - Astellas Pharma
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Genzyme Corporation
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Accord Healthcare Ltd.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Watson Pharmaceuticals, Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Novartis AG
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Mylan Laboratories, Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - GlaxoSmithKline plc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Belcher Pharmaceuticals LLC
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Leo Pharma As
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Glenmark Pharmaceuticals Ltd.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - TFF Pharmaceuticals, Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - TolerogenixX GmbH
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Veloxis Pharmaceuticals Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Dr. Reddy’s Laboratories Ltd.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Panacea Biotec Ltd.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Strides Pharma Global Pte Ltd.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Hoffman La Roche
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
- Analysts’ Views
Section
- References
- Research Methodology
- About us and Sales Contact

*Browse 32 market data tables and 28 figures on “Global Organ Transplant Immunosuppressant Drugs Market” - Global forecast to 2030

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now